Investigation of binding proteins for anti-platelet agent K-134 by Drug-Western method.
Investigation of binding proteins for anti-platelet agent K-134 by Drug-Western method.
复制标题
通过 Drug-Western 方法研究抗血小板剂 K-134 的结合蛋白。
DOI:
10.1016/j.bbrc.2006.12.172
复制
发表时间:
2007
影响因子:
3.1
通讯作者:
H. Hidaka
中科院分区:
文献类型:
--
作者:
M. Ikenoya;T. Doi;T. Miura;K. Sawanobori;M. Nishio;H. Hidaka
K-134 ((–)-6-[3-[3-cyclopropyl-3-[(1R, 2R)-2-hydroxycyclohexyl]ureido]-propoxy]-2(1H)-quinolinone) is a novel anti-platelet agent with anti-hyperplastic activities. We found previously that K-134 is a potent phosphodiesterase-3 (PDE3) inhibitor. In the present study, we found other K-134-binding proteins by Drug-Western method. We isolated two clones that can bind directly to K-134, cofilin-2, and CD36 in vitro. Comparison of their amino acid sequences showed similarity over a short stretch [KxxxxVxIxWxxE] in part in the collagen-binding region of CD36. K-134 inhibited binding between CD36 and collagen type-I; however, other PDE3 inhibitors, cilostazol, amrinone, and an inactive derivative of K-134, 4S-OH-K-134, showed little or no effect on binding. It was strongly suggested that the direct binding between K-134 and CD36 is a characteristic effect of K-134, and the homologous stretch may be necessary for binding to K-134. These results also suggested that these interactions are involved in the mechanisms of the anti-platelet and anti-hyperplastic effects of K-134.
影响因子:
20.3
作者:
D. Greenwalt;Robert Lipsky;C. Ockenhouse;H. Ikeda;N. Tandon;G. Jamieson
通讯作者:
D. Greenwalt;Robert Lipsky;C. Ockenhouse;H. Ikeda;N. Tandon;G. Jamieson
DOI:
10.1161/01.atv.16.7.883
发表时间:
1996
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
Diaz-Ricart,M;Tandon,NN;Gómez-Ortiz,G;Carretero,M;Escolar,G;Ordinas,A;Jamieson,GA
通讯作者:
Jamieson,GA